CNPase Antibodies

Santa Cruz Biotechnology features a diverse variety of CNPase monoclonal antibodies for investigating 2',3'-cyclic nucleotide 3'-phosphodiesterase (CNPase) in various biological processes. CNPase monoclonal antibodies are compatible with multiple research applications including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). CNPase is a critical enzyme involved in the metabolism of cyclic nucleotides, playing a significant role in myelination and neuronal function. CNPase expression is particularly abundant in oligodendrocytes, where it contributes to the formation and maintenance of myelin sheaths in the central nervous system. Research focused on CNPase activity provides valuable insights into mechanisms underlying neurodegenerative diseases and demyelinating disorders. CNPase monoclonal antibodies enable researchers to explore cellular pathways and molecular mechanisms related to myelin development and maintenance. CNPase monoclonal antibodies support cutting-edge neuroscience research aimed at understanding neurological conditions and developing potential therapeutic strategies. Santa Cruz Biotechnology monoclonal antibodies for CNPase detection help advance scientific understanding of myelin biology and neurological disease mechanisms.